GNH USA

Europe — EMA

Latanoprost/Timolol Aurovitas

GNH USA supplies Latanoprost/Timolol Aurovitas (Latanoprost/Timolol), a prostaglandin analog/beta‑blocker combination for open‑angle glaucoma and ocular

Timolol Maleate, Latanoprost

Request sourcing

1
Pack/s

What is Timolol Maleate, Latanoprost?

Latanoprost, the active ingredient in Latanoprost/Timolol Aurovitas, is a prostaglandin analog presented as an eye drop for ocular use. Combined with timolol maleate, it treats open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost/Timolol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Timolol Maleate, Latanoprost used for?

Latanoprost/Timolol is used in the management of glaucoma and ocular hypertension, conditions characterized by elevated intra‑ocular pressure.

- Open‑angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage. - Ocular hypertension: lowers intra‑ocular pressure to prevent progression to glaucoma. - Secondary open‑angle glaucoma (e.g., pseudoexfoliative): assists in pressure control when monotherapy is insufficient.

What are the side effects of Timolol Maleate, Latanoprost?

Common Side Effects: - Eye irritation: mild burning or stinging after instillation. - Blurred vision: transient visual disturbance. - Eye redness: conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual pigmentation change. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Worsening of asthma or COPD: bronchospasm. - Bradycardia: markedly slow heart rate. - Hypotension: significant drop in blood pressure. - Chest pain or myocardial ischemia. - Ocular inflammation: uveitis or keratitis.

What precautions apply to Timolol Maleate, Latanoprost?

Before using Latanoprost/Timolol, consider the following precautions.

- Pregnancy: safety not established; avoid unless benefit outweighs risk. - Breastfeeding: unknown excretion; assess potential infant exposure. - Respiratory disease: use with caution in patients with asthma or COPD. - Cardiovascular disease: monitor heart rate and blood pressure regularly. - Drug interactions: avoid concurrent use of other non‑selective beta‑blockers. - Store at room temperature: keep in the original container, protect from light and moisture.

What does Timolol Maleate, Latanoprost interact with?

Latanoprost/Timolol may interact with other medicines; review the following.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and hypotension. - Calcium channel blockers: may enhance ocular hypotensive effect. - Monoamine oxidase inhibitors: potential systemic cardiovascular effects.

Moderate Interactions (Monitor Closely): - Other prostaglandin analogs: increased ocular irritation. - Systemic antihypertensives: monitor blood pressure for additive lowering. - Bronchodilators: may reduce timolol efficacy, requiring respiratory monitoring.

Frequently asked questions

What is Latanoprost/Timolol Aurovitas used for?+
Latanoprost/Timolol Aurovitas is a prescription eye‑drop formulation indicated for the reduction of intra‑ocular pressure in patients with open‑angle glaucoma and ocular hypertension. By lowering pressure, it helps to prevent optic nerve damage and preserve visual function.
How does the combination of Latanoprost and Timolol work?+
Latanoprost increases the outflow of aqueous humor through the uveoscleral pathway by activating prostaglandin F receptors, while Timolol blocks beta‑adrenergic receptors to reduce aqueous humor production. The dual mechanism results in a greater overall decrease in intra‑ocular pressure than either component alone.
What is the usual dose of Latanoprost/Timolol Aurovitas?+
The dosing regimen for Latanoprost/Timolol Aurovitas is determined by the prescribing ophthalmologist based on the individual patient's condition, response, and tolerance. Typically, one drop is instilled into the affected eye(s) once daily, but the exact schedule must follow the prescriber’s instructions.
Is Latanoprost/Timolol safe during pregnancy or breastfeeding?+
Safety data for Latanoprost/Timolol in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Latanoprost/Timolol Aurovitas from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.
How does Latanoprost/Timolol compare with monotherapy options?+
Compared with single‑agent therapy, the Latanoprost/Timolol combination offers additive intra‑ocular pressure reduction because it targets both aqueous humor outflow and production. This often results in better pressure control for patients who do not achieve target levels with either prostaglandin analog or beta‑blocker alone.
What are the storage and handling requirements for this eye‑drop?+
Latanoprost/Timolol eye drops should be stored at room temperature, below 25 °C, in the original packaging. Protect the product from direct sunlight and moisture. Keep the bottle tightly closed when not in use and discard any solution that appears discolored or contains particles.
How is Latanoprost/Timolol administered?+
The medication is applied as a sterile ophthalmic solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place one drop into the conjunctival sac of the prescribed eye(s). Close the eye gently and avoid blinking excessively for a few seconds.
What are the most serious risks associated with Latanoprost/Timolol?+
Serious risks include severe allergic reactions, bronchospasm in patients with asthma or COPD, marked bradycardia, hypotension, and ocular inflammation such as uveitis. Patients should seek immediate medical attention if they experience difficulty breathing, chest pain, rapid heartbeat changes, or significant eye pain.
Who should not use Latanoprost/Timolol Aurovitas?+
The product is contraindicated in patients with known hypersensitivity to either component, those with severe sinus node dysfunction, uncontrolled asthma or COPD, and individuals using non‑selective beta‑blockers systemically. It should also be avoided in patients with certain cardiac conduction disorders unless specifically directed by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Timolol Maleate, Latanoprost
Route
Ocular Use
Manufacturer
Aurovitas, Spol. S R.O.
Origin
EU

Related products